1. Market Research
  2. > Biotechnology
  3. > Biopharmaceutical Market Trends
  4. > Autoimmune Drug Focus SEPTEMBER 2016

Autoimmune Drug Focus SEPTEMBER 2016

  • September 2016
  • -
  • Espicom Business Intelligence
  • -
  • 20 pages

Industry Trend Analysis - Amjevita Approval Reinforces Amgen's Biosimilar Market View
Industry Brief - Novo Nordisk Recalls Six Batches Of GlucaGen HypoKit
Industry Brief - Sotagliflozin Meets Primary Endpoint In Phase III Type I Diabetes Study
Industry Trend Analysis - Mounting Pressure Decreases Lantus' Sales Potential In 2017
Industry Brief - CHMP Recommends Marketing Authorisation For Stelara In CD
Industry Brief - FDA Approves Stelara For CD Indication
Industry Brief - Gilead Terminates GS-5745 Phase II/III Study In UC
Industry Brief - Copaxone 40mg/mL Thrice Weekly Injection Approved In Canada To Treat RRMS
Industry Trend Analysis - Secondary Progressive MS Breakthrough Revitalises Novartis Ambitions
Industry Brief - US PTO Ruling Favours Mylan In Copaxone 40mg IPR Challenge
Industry Brief - RedHill Biopharma Receives Approval Of European Patent For RHB-104 In MS
Industry Trend Analysis - Copaxone's Generic Vulnerability Increases
Industry Trend Analysis - Progressive Symptoms Will Become The Focus Of MS Drug Development
Industry Trend Analysis - Sandoz' Biosimilar Etanercept Approval Edges US Market Forward
Industry Brief - Chugai Seeks Japanese Approval For Actemra Additional Dosage In RA
Industry Brief - Orencia Granted EC Approval As RA Treatment In Adults
Industry Brief - GSK Seeks European MAA For Sirukumab In RA
Industry Brief - Samsung Gains First Health Canada Biosimilar Etanercept Approval
Industry Brief - Pfizer's Biosimilar Infliximab Achieves Positive Top-Line Results
Industry Brief - CHMP Recommends Use Of Cimzia AutoClicks Prefilled Pen
Industry Brief - Janssen Seeks Sirukumab BLA Approval In RA
Industry Brief - Daiichi Sankyo Seeks Labelling Update For Pralia In Japan
Industry Trend Analysis - Firdapse Will Tread Increasingly Fraught Line Between Access And Overheads
Industry Brief - Galectin Reports Interim Results From GR-MD-02 Phase IIa Psoriasis Trial
Industry Brief - Can-Fite's CF-101 Granted EU Patent Allowance
Industry Brief - Allergan To Acquire Vitae For Dermatologic Conditions
Industry Brief - Dosing Commences InKD025 Phase II Psoriasis Trial
Industry Brief - MacroGenics Regains Worldwide Rights To MGD01O
Industry Brief - Delinia Completes Fundraising To Advance Treg Therapy
Industry Trend Analysis - Rigel Gambling On ITP Success
Industry Brief - GSK Seeks US/EU Approval For Benlysta SC In SLE
Industry Brief - Autoimmune Conferences - December 2016

Table Of Contents

Autoimmune Drug Focus SEPTEMBER 2016

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
2016 Europe Cancer Diagnostics Market: Supplier Shares, Country Volume and Sales Segment Forecasts, Innovative Technologies, Competitive Strategies--France, Germany, Italy, Spain, UK

2016 Europe Cancer Diagnostics Market: Supplier Shares, Country Volume and Sales Segment Forecasts, Innovative Technologies, Competitive Strategies--France, Germany, Italy, Spain, UK

  • $ 12800
  • Industry report
  • September 2016
  • by Venture Planning Group

Complete report $19,700.  DataPack (test volumes, sales forecasts, supplier shares) $12,800. VPGMarketResearch’s new report is a study of the major business opportunities emerging in the European cance ...

R&D Drug Pipeline Database: 1-Year Subscription

R&D Drug Pipeline Database: 1-Year Subscription

  • $ 6600
  • Industry report
  • November 2016
  • by La Merie Publishing

R&D Drug Pipeline Database: 1-Year Subscription Subscription to La Merie Publishing’s proprietary R&D Drug Pieline Database provides 24/7 online access to information about more than 21,000 project entries ...

Cancer Vaccines: Technologies and Global Markets

Cancer Vaccines: Technologies and Global Markets

  • $ 6650
  • Industry report
  • November 2016
  • by BCC Research

This cancer vaccines report by BCC Research explores present and future strategies within the market which includes prophylactic vaccines and therapeutic vaccines. Use this report to: - Analyze the global ...


ref:plp2016

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.